Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study.

Walter T, Lepage C, Coriat R, Barbier E, Cadiot G, Caroli-Bosc FX, Aparicio T, Bouhier-Leporrier K, Hentic-Dhome O, Gay F, Dupont-Gossart AC, Duluc M, Lepere C, Lecomte T, Smith D, Petorin C, Di-Fiore F, Ghiringhelli F, Legoux JL, Guimbaud R, Baudin E, Lombard-Bohas C, de Baère T; FFCD 1104 investigators/investigators.

Eur J Cancer. 2019 Oct 31;123:92-100. doi: 10.1016/j.ejca.2019.09.021. [Epub ahead of print]

PMID:
31678771
2.

Stakeholders' Role and Actions in the Return-to-Work Process of Workers on Sick-Leave Due to Common Mental Disorders: A Scoping Review.

Corbière M, Mazaniello-Chézol M, Bastien MF, Wathieu E, Bouchard R, Panaccio A, Guay S, Lecomte T.

J Occup Rehabil. 2019 Oct 31. doi: 10.1007/s10926-019-09861-2. [Epub ahead of print] Review.

PMID:
31673934
3.

Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE).

Fine C, Roquin G, Terrebonne E, Lecomte T, Coriat R, Do Cao C, de Mestier L, Coffin E, Cadiot G, Nicolli P, Lepiliez V, Hautefeuille V, Ramos J, Girot P, Dominguez S, Céphise FV, Forestier J, Hervieu V, Pioche M, Walter T.

United European Gastroenterol J. 2019 Oct;7(8):1102-1112. doi: 10.1177/2050640619861883. Epub 2019 Jul 4.

4.

Efficacy and Safety of Aflibercept in Combination With Chemotherapy Beyond Second-Line Therapy in Metastatic Colorectal Carcinoma Patients: An AGEO Multicenter Study.

Auvray M, Tougeron D, Auclin E, Moulin V, Artru P, Hautefeuille V, Hammel P, Lecomte T, Locher C, Sickersen G, Coriat R, Lecaille C, Vernerey D, Taieb J, Pernot S.

Clin Colorectal Cancer. 2019 Sep 4. pii: S1533-0028(19)30090-8. doi: 10.1016/j.clcc.2019.08.003. [Epub ahead of print]

PMID:
31648924
5.

Does the Beck Cognitive Insight Scale predict change in delusional beliefs?

Penzenstadler L, Chatton A, Lecomte T, Huguelet P, Lecardeur L, Azoulay S, Bartolomei J, Brazo P, Murys E, Poupart F, Rouvière S, Parabiaghi A, Saoud M, Favrod J, Khazaal Y.

Psychol Psychother. 2019 Oct 4:e12253. doi: 10.1111/papt.12253. [Epub ahead of print]

PMID:
31583824
6.

Complete Pathological Response Following Radiochemotherapy for Locally Advanced Rectal Cancer: Short and Long-term Outcome.

Iskander O, Courtot L, Tabchouri N, Artus A, Michot N, Muller O, Pabst-Giger U, Bourlier P, Kraemer-Bucur A, Lecomte T, Guyetant S, Chapet S, Calais G, Salamé E, Ouaïssi M.

Anticancer Res. 2019 Sep;39(9):5105-5113. doi: 10.21873/anticanres.13705.

PMID:
31519622
7.

Back-to-Back Comparison of Colonoscopy With Virtual Chromoendoscopy Using a Third-Generation Narrow-Band Imaging System to Chromoendoscopy With Indigo Carmine in Patients With Lynch Syndrome.

Cellier C, Perrod G, Colas C, Dhooge M, Saurin JC, Lecomte T, Coron E, Rahmi G, Savale C, Chaussade S, Bellanger J, Dray X, Benech N, Le Rhun M, Barbieux JP, Pereira H, Chatellier G, Samaha E.

Am J Gastroenterol. 2019 Oct;114(10):1665-1670. doi: 10.14309/ajg.0000000000000386.

PMID:
31498154
8.

Video intervention for the psychiatric waiting room: proof-of-concept randomised controlled trial of RESOLVE (Relaxation Exercise, SOLVing problem and cognitive Errors).

Naeem F, Munshi T, Gratzer D, Rodie D, Irfan M, Rao S, Husain N, Farooq S, Sanches M, Ayub M, Lecomte T.

BJPsych Open. 2019 Sep 6;5(5):e77. doi: 10.1192/bjo.2019.59.

9.

Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study.

Gallois C, Artru P, Lièvre A, Auclin E, Lecomte T, Locher C, Marthey L, Zaimi Y, Faroux R, Pernot S, Barret M, Taieb J.

Eur J Cancer. 2019 Sep;119:35-43. doi: 10.1016/j.ejca.2019.07.011. Epub 2019 Aug 12.

PMID:
31415985
10.

Low Tie Compared to High Tie Vascular Ligation of the Inferior Mesenteric Artery in Rectal Cancer Surgery Decreases Postoperative Complications Without Affecting Overall Survival.

Nayeri M, Iskander O, Tabchouri N, Artus A, Michot N, Muller O, Giger-Pabst U, Bourlier P, Kraemer-Bucur A, Lecomte T, Salame E, Ouaissi M.

Anticancer Res. 2019 Aug;39(8):4363-4370. doi: 10.21873/anticanres.13605.

PMID:
31366531
11.

Enhancing Nab-Paclitaxel Delivery Using Microbubble-Assisted Ultrasound in a Pancreatic Cancer Model.

Bressand D, Novell A, Girault A, Raoul W, Fromont-Hankard G, Escoffre JM, Lecomte T, Bouakaz A.

Mol Pharm. 2019 Sep 3;16(9):3814-3822. doi: 10.1021/acs.molpharmaceut.9b00416. Epub 2019 Aug 6.

PMID:
31356090
12.

Predicting and preventing symptom onset and relapse in schizophrenia-A metareview of current empirical evidence.

Lecomte T, Potvin S, Samson C, Francoeur A, Hache-Labelle C, Gagné S, Boucher J, Bouchard M, Mueser KT.

J Abnorm Psychol. 2019 Nov;128(8):840-854. doi: 10.1037/abn0000447. Epub 2019 Jul 25.

PMID:
31343181
13.

BRAF Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study.

Mas L, Bachet JB, Taly V, Bouché O, Taieb J, Cohen R, Meurisse A, Normand C, Gornet JM, Artru P, Louafi S, Thirot-Bidault A, Baumgaertner I, Coriat R, Tougeron D, Lecomte T, Mary F, Aparicio T, Marthey L, Blons H, Vernerey D, Laurent-Puig P.

Cancers (Basel). 2019 Jul 17;11(7). pii: E998. doi: 10.3390/cancers11070998.

14.

Impact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial.

Charton E, Bachet JB, Hammel P, Desramé J, Chibaudel B, Cohen R, Debourdeau P, Dauba J, Lecomte T, Seitz JF, Tournigand C, Aparicio T, Guerin-Meyer V, Taieb J, Volet J, Louvet C, Anota A, Bonnetain F.

Cancer Med. 2019 Sep;8(11):5079-5088. doi: 10.1002/cam4.2311. Epub 2019 Jul 17.

15.

Can social firms contribute to alleviating the economic burden of psychiatric disabilities for the public healthcare system?

Sultan-Taïeb H, Villotti P, Berbiche D, Dewa CS, Desjardins É, Fraccaroli F, Zaniboni S, Mazaniello-Chézol M, Lecomte T, Durand MJ, Corbière M.

Health Soc Care Community. 2019 Sep;27(5):1311-1320. doi: 10.1111/hsc.12775. Epub 2019 May 31.

PMID:
31149764
16.

Mobile Intervention for Individuals With Psychosis, Dual Disorders, and Their Common Comorbidities: A Literature Review.

Pennou A, Lecomte T, Potvin S, Khazaal Y.

Front Psychiatry. 2019 May 3;10:302. doi: 10.3389/fpsyt.2019.00302. eCollection 2019. Review.

17.

Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma.

Jouve JL, Lecomte T, Bouché O, Barbier E, Khemissa Akouz F, Riachi G, Nguyen Khac E, Ollivier-Hourmand I, Debette-Gratien M, Faroux R, Villing AL, Vergniol J, Ramee JF, Bronowicki JP, Seitz JF, Legoux JL, Denis J, Manfredi S, Phelip JM; PRODIGE-11 investigators/collaborators.

J Hepatol. 2019 Sep;71(3):516-522. doi: 10.1016/j.jhep.2019.04.021. Epub 2019 May 22.

PMID:
31125576
18.

Expression Profiling of Calcium Channels and Calcium-Activated Potassium Channels in Colorectal Cancer.

Ibrahim S, Dakik H, Vandier C, Chautard R, Paintaud G, Mazurier F, Lecomte T, Guéguinou M, Raoul W.

Cancers (Basel). 2019 Apr 19;11(4). pii: E561. doi: 10.3390/cancers11040561.

19.

Usefulness of confocal laser endomicroscopy for predicting postoperative recurrence in patients with Crohn's disease: a pilot study.

Auzoux J, Boschetti G, Anon B, Aubourg A, Caulet M, Poisson L, Besson P, Lecomte T, Roger S, Picon L, Nancey S, Moussata D, Flourie B.

Gastrointest Endosc. 2019 Jul;90(1):151-157. doi: 10.1016/j.gie.2019.02.030. Epub 2019 Mar 5.

PMID:
30849396
20.

Can Social Anxiety Impact Facial Emotion Recognition in Schizophrenia?

Lecomte T, Théroux L, Paquin K, Potvin S, Achim A.

J Nerv Ment Dis. 2019 Mar;207(3):140-144. doi: 10.1097/NMD.0000000000000934.

PMID:
30720605
21.

Work productivity of people with a psychiatric disability working in social firms.

Corbière M, Zaniboni S, Dewa CS, Villotti P, Lecomte T, Sultan-Taïeb H, Hupé J, Fraccaroli F.

Work. 2019;62(1):151-160. doi: 10.3233/WOR-182850.

PMID:
30689598
22.

A study of the association between UGT1A1*28 variant allele of UGT1A1 gene and colonic phenotype of sporadic colorectal cancer.

Anon B, Perray C, Regnault D, Caulet M, Orain I, Godart B, Pages JC, Tallet A, Ouaissi M, Guyetant S, Barin-le Guellec C, Lecomte T.

Dig Liver Dis. 2019 Apr;51(4):579-583. doi: 10.1016/j.dld.2018.11.032. Epub 2018 Dec 10.

PMID:
30583998
23.

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.

Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Choné L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, O'Callaghan CJ, Jouffroy-Zeller C, Rat P, Malka D, Castan F, Bachet JB; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group.

N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775.

PMID:
30575490
24.

Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort study.

Rompteaux P, Gagnière J, Gornet JM, Coriat R, Baumgaertner I, Lecomte T, Afchain P, Zaanan A, Pocard M, Bachet JB, Bonichon-Lamichhane N, Bouché O, Faucheron JL, Forestier J, Lecaille C, Manfredi S, Tougeron D, Terrebonne E, Chehimi M, Villing AL, Sarda C, Legoux JL, Benamouzig R, Aparicio T.

Eur J Surg Oncol. 2019 Mar;45(3):331-335. doi: 10.1016/j.ejso.2018.11.012. Epub 2018 Nov 22.

PMID:
30501999
25.

A melanosis coli associated with a large flat adenoma of the cecum.

Lecomte T, Chautard R, Orain I.

Clin Res Hepatol Gastroenterol. 2019 Jun;43(3):228-229. doi: 10.1016/j.clinre.2018.10.006. Epub 2018 Nov 15. No abstract available.

PMID:
30447908
26.

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial.

Bachet JB, Lucidarme O, Levache CB, Barbier E, Raoul JL, Lecomte T, Desauw C, Brocard F, Pernot S, Breysacher G, Lagasse JP, Di Fiore F, Etienne PL, Dupuis OJM, Aleba A, Lepage C, Taieb J; for FFCD 1102 investigators.

Eur J Cancer. 2018 Nov;104:108-116. doi: 10.1016/j.ejca.2018.09.006. Epub 2018 Oct 18.

PMID:
30343254
27.

EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib.

Bouché O, Cesne AL, Rios M, Chaigneau L, Italiano A, Duffaud F, Lecomte T, Arsène D, Manfredi S, Aparicio T, Remy S, Isambert N, Collard O, Priou F, Bertucci F, Sambuc R, Bisot-Locard S, Bourges O, Chabaud S, Blay JY.

PLoS One. 2018 Sep 18;13(9):e0204117. doi: 10.1371/journal.pone.0204117. eCollection 2018.

28.

The prevalence of substance-induced psychotic disorder in methamphetamine misusers: A meta-analysis.

Lecomte T, Dumais A, Dugré JR, Potvin S.

Psychiatry Res. 2018 Oct;268:189-192. doi: 10.1016/j.psychres.2018.05.033. Epub 2018 May 17.

PMID:
30041133
29.

Acceptance and Commitment Therapy for Psychosis and Trauma: Investigating Links between Trauma Severity, Attachment and Outcome.

Spidel A, Daigneault I, Kealy D, Lecomte T.

Behav Cogn Psychother. 2019 Mar;47(2):230-243. doi: 10.1017/S1352465818000413. Epub 2018 Jul 17.

PMID:
30012233
30.

Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.

Lièvre A, Ouine B, Canet J, Cartier A, Amar Y, Cacheux W, Mariani O, Guimbaud R, Selves J, Lecomte T, Guyetant S, Bieche I, Berger F, de Koning L.

Br J Cancer. 2018 Aug;119(3):387. doi: 10.1038/s41416-018-0130-x.

31.

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.

Aparicio T, Ducreux M, Faroux R, Barbier E, Manfredi S, Lecomte T, Etienne PL, Bedenne L, Bennouna J, Phelip JM, François E, Michel P, Legoux JL, Gasmi M, Breysacher G, Rougier P, De Gramont A, Lepage C, Bouché O, Seitz JF; for FFCD investigators.

Eur J Cancer. 2018 Jul;98:1-9. doi: 10.1016/j.ejca.2018.03.031. Epub 2018 May 26.

32.

Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer.

Aparicio T, Bouché O, Francois E, Retornaz F, Barbier E, Taieb J, Kirscher S, Etienne PL, Faroux R, Khemissa Akouz F, El Hajbi F, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Bedenne L, Paillaud E; for PRODIGE 20 investigators.

Eur J Cancer. 2018 Jul;97:16-24. doi: 10.1016/j.ejca.2018.03.030. Epub 2018 May 16.

PMID:
29777975
33.

Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity.

Anon B, Largeau B, Girault A, Chantome A, Caulet M, Perray C, Moussata D, Vandier C, Barin-Le Guellec C, Lecomte T.

Cancer Chemother Pharmacol. 2018 Jul;82(1):149-157. doi: 10.1007/s00280-018-3600-1. Epub 2018 May 17.

PMID:
29774408
34.

Implementing cognitive behavioral therapy for psychosis: An international survey of clinicians' attitudes and obstacles.

Lecomte T, Samson C, Naeem F, Schachte L, Farhall J.

Psychiatr Rehabil J. 2018 Jun;41(2):141-148. doi: 10.1037/prj0000292. Epub 2018 May 3.

PMID:
29723013
35.

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.

Aparicio T, Bouché O, Taieb J, Maillard E, Kirscher S, Etienne PL, Faroux R, Khemissa Akouz F, El Hajbi F, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Paillaud E, Retornaz F, François E, Bedenne L; for PRODIGE 20 Investigators.

Ann Oncol. 2018 Nov 1;29(11):2270. doi: 10.1093/annonc/mdx808. No abstract available.

36.

Psychotic disorders in sexually abused youth: A prospective matched-cohort study.

Bourgeois C, Lecomte T, Daigneault I.

Schizophr Res. 2018 Sep;199:123-127. doi: 10.1016/j.schres.2018.03.020. Epub 2018 Mar 13.

PMID:
29548761
37.

RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study.

Bachet JB, Bouché O, Taieb J, Dubreuil O, Garcia ML, Meurisse A, Normand C, Gornet JM, Artru P, Louafi S, Bonnetain F, Thirot-Bidault A, Baumgaertner I, Coriat R, Tougeron D, Lecomte T, Mary F, Aparicio T, Marthey L, Taly V, Blons H, Vernerey D, Laurent-Puig P.

Ann Oncol. 2018 May 1;29(5):1211-1219. doi: 10.1093/annonc/mdy061.

PMID:
29438522
38.

Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis.

Potvin S, Pelletier J, Grot S, Hébert C, Barr AM, Lecomte T.

Addict Behav. 2018 May;80:154-160. doi: 10.1016/j.addbeh.2018.01.021. Epub 2018 Jan 31. Review.

PMID:
29407687
39.

Development and validation of an ELISA to study panitumumab pharmacokinetics.

Desvignes C, Passot C, Ternant D, Caulet M, Guérineau C, Lecomte T, Paintaud G.

Bioanalysis. 2018 Feb;10(4):205-214. doi: 10.4155/bio-2016-0292. Epub 2018 Jan 18.

PMID:
29345521
40.

Pharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumab.

Ibrahim S, Raoul W, Lecomte T, Paintaud G, Ternant D.

Eur J Cancer. 2018 Mar;92:119-120. doi: 10.1016/j.ejca.2017.12.004. Epub 2018 Jan 9. No abstract available.

41.

[Return to Work Strategies of Employees who Experienced Depression: Employers and HR's Perspectives].

Corbière M, Lecomte T, Lachance JP, Coutu MF, Negrini A, Laberon S.

Sante Ment Que. Fall 2017;42(2):173-196. French.

PMID:
29267420
42.
43.

Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study.

Palle J, Tougeron D, Pozet A, Soularue E, Artru P, Leroy F, Dubreuil O, Sarabi M, Williet N, Manfredi S, Martin-Babau J, Rebischung C, Abdelghani MB, Evesque L, Dreanic J, Hautefeuille V, Louafi S, Sefrioui D, Savinelli F, Mabro M, Rousseau B, Lecaille C, Bouché O, Louvet C, Lecomte T, Bonnetain F, Taieb J, Zaanan A.

Oncotarget. 2017 Sep 8;8(60):101383-101393. doi: 10.18632/oncotarget.20711. eCollection 2017 Nov 24.

44.

Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration.

Ternant D, Passot C, Aubourg A, Goupille P, Desvignes C, Picon L, Lecomte T, Mulleman D, Paintaud G.

Clin Pharmacokinet. 2018 Sep;57(9):1173-1184. doi: 10.1007/s40262-017-0621-6.

PMID:
29236229
45.

Value of Contrast-Enhanced Ultrasound Quantification Criteria for Identifying Patients not Responding to Bevacizumab-Based Therapy for Colorectal Liver Metastases.

Tranquart F, Dujardin PA, Bouché O, Marcus C, Borg C, Manzoni P, Douillard JY, Labbe-Devilliers C, Terrebonne E, Smith D, Trillaud H, Capitain O, Aubé C, Spano JP, Lucidarme O, Ferru A, Tasu JP, Manfredi S, Bleuzen A, Léger J, Lecomte T.

Ultraschall Med. 2018 Oct;39(5):544-558. doi: 10.1055/s-0043-122497. Epub 2017 Dec 12.

PMID:
29232725
46.

Clinical outcome of portal vein thrombosis in patients with digestive cancers: A large AGEO multicenter study.

Regnault H, Emambux S, Lecomte T, Doat S, Dhooge M, Besson M, Dubreuil O, Moryoussef F, Silvain C, Bachet JB, Tougeron D.

Dig Liver Dis. 2018 Mar;50(3):285-290. doi: 10.1016/j.dld.2017.11.001. Epub 2017 Nov 16.

PMID:
29183764
47.

Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study.

Salimon M, Prieux-Klotz C, Tougeron D, Hautefeuille V, Caulet M, Gournay J, Matysiak-Budnik T, Bennouna J, Tiako Meyo M, Lecomte T, Zaanan A, Touchefeu Y.

Br J Cancer. 2018 Feb 6;118(3):325-330. doi: 10.1038/bjc.2017.413. Epub 2017 Nov 23.

48.

Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer?

Ibrahim S, Girault A, Ohresser M, Lereclus E, Paintaud G, Lecomte T, Raoul W.

Clin Colorectal Cancer. 2018 Mar;17(1):e109-e113. doi: 10.1016/j.clcc.2017.10.003. Epub 2017 Oct 28. Review.

49.

Ca2+ protein alpha 1D of CaV1.3 regulates intracellular calcium concentration and migration of colon cancer cells through a non-canonical activity.

Fourbon Y, Guéguinou M, Félix R, Constantin B, Uguen A, Fromont G, Lajoie L, Magaud C, Lecomte T, Chamorey E, Chatelier A, Mignen O, Potier-Cartereau M, Chantôme A, Bois P, Vandier C.

Sci Rep. 2017 Oct 27;7(1):14199. doi: 10.1038/s41598-017-14230-1.

50.

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.

Aparicio T, Bouché O, Taieb J, Maillard E, Kirscher S, Etienne PL, Faroux R, Khemissa Akouz F, El Hajbi F, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Paillaud E, Retornaz F, François E, Bedenne L; for PRODIGE 20 Investigators.

Ann Oncol. 2018 Jan 1;29(1):133-138. doi: 10.1093/annonc/mdx529. Erratum in: Ann Oncol. 2018 Nov 1;29(11):2270.

Supplemental Content

Loading ...
Support Center